BIEL Triggers...
* May 15th Q1 Financial Report - If BIEL can show a significant increase in sales, most likely caused by the NHS ramp up, this will support the company statements that "the NHS win is transformational for the company".
Other revenues from Licensing/Co-branding have been said to possibly show up as early as Q1.
* May 9th FDA Back Pain Meeting - BIEL should provide a statement shortly after this meeting. The FDA wanted a Clinical Trial on a third body area to consider a "Full Body Clearance". BIEL has provided a 100 patient Back Pain Trial to support the addition of the Back as an indication for ActiPatch and Full Body Clearance. Those with knowledge of the process have indicated that a new 510k will not be needed but rather that the Back will be treated as an addition to the successful 2/3/2017 Clearance for Foot and Knee.
* May 29th FDA Post Operative Pain Meeting - Data was sent to FDA, BIEL received a quick response for the 5/29 meeting. IMO this should be a Slam Dunk with the B.Braun surgical use in the UK and now with the new NHS/B.Braun "Total Pathways Program" rolling out.
* Time frame, Any Day Now, Bayer/Dr. Scholl's Partnership - On 4/26 BIEL's VP of Sales stated that BIEL was "close to finalizing a deal to partner on a product with Dr. Scholl's". Dr. Scholl's is owned by Big Pharma Giant Bayer. When this gets a PR we will see a billion share trading day with Extreme Upward Pressure.
* Time frame, Any Day Now, MundiPharma Distribution - "Australia and 8 other countries" KN. Mundi is a global billion dollar company. This deal has not yet received an official BIEL PR, when it does it is another big catalyst for the BIEL SP.
* Time frame, Any Day Now, Performance Health (formerly Patterson Medical) - Another billion dollar global company wanting to do distribution business with BIEL. As with Mundi waiting on an official PR stating Performance is a distributor which gives BIEL instant medical community credibility.
* Time frame, Any Day Now, B.Braun/NHS Total Pathways Program - This was the Big Surprise from the latest KN interview. There was speculation re the Dr. Scholl's Deal for months so the 4/26 confirmation was fantastic but it was a possibility. The B.Braun Total Pathways was a complete surprise. Those darn privately held companies can sure keep their secrets. Major Plus, placing joint surgery patients on ActiPatch while they wait for surgery as this wait can last a year. Once again when this gets a BIEL PR major boost for the company.
This is only a partial list of events that will impact the BIEL SP. We did not even touch on the prospects for the Migraine Clinical trial, the Menstrual Pain Clinical Trial, or the Total Knee Replacement Trial. I am sure there are several other events that are on the horizon that I am missing.
BIEL has a stock pile of fuel and will keep things exciting throughout 2018!
